Research Output per year
Fingerprint Dive into the research topics where Kevin Van Cott is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Self assembled monolayers
Chemical Compounds
Recombinant Proteins
Medicine & Life Sciences
Swine
Medicine & Life Sciences
Chromophores
Chemical Compounds
Protein C
Medicine & Life Sciences
Self assembly
Engineering & Materials Science
Factor IX
Medicine & Life Sciences
Multilayers
Engineering & Materials Science
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1991 2019
1
Citation
(Scopus)
Methylation deficiency of chromatin proteins is a non-mutational and epigenetic-like trait in evolved lines of the archaeon Sulfolobus solfataricus
Johnson, T., Payne, S., Grove, R., McCarthy, S., Oeltjen, E., Mach, C., Adamec, J., Wilson, M. A., Van Cott, K. & Blum, P. H., Jan 1 2019, In : Journal of Biological Chemistry. 294, 19, p. 7821-7832 12 p.Research output: Contribution to journal › Article
Sulfolobus solfataricus
Protein Deficiency
Methylation
Archaea
Epigenomics
3
Citations
(Scopus)
Experience with host cell protein impurities in biopharmaceuticals
Vanderlaan, M., Zhu-Shimoni, J., Lin, S., Gunawan, F., Waerner, T. & Van Cott, K., Jul 1 2018, In : Biotechnology Progress. 34, 4, p. 828-837 10 p.Research output: Contribution to journal › Review article
Industry
Proteins
Patents
History
Safety
Secretion and fusion of biogeochemically active archaeal membrane vesicles
Johnson, T. B., Mach, C., Grove, R., Kelly, R., Van Cott, K. & Blum, P. H., Jan 1 2018, (Accepted/In press) In : Geobiology.Research output: Contribution to journal › Article
vesicle
secretion
copper
membrane
Crenarchaeota
Repurposed bacterial toxins for human therapeutics
Pavlik, B. J., Van Cott, K. & Blum, P. H., Jan 1 2017, In : Current Topics in Peptide and Protein Research. 18, p. 1-15 15 p.Research output: Contribution to journal › Review article
Bacterial Toxins
Drug delivery
Proteins
Drug Repositioning
Macromolecular Substances
7
Citations
(Scopus)
Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph
Monroe, D. M., Jenny, R. J., Van Cott, K., Buhay, S. & Saward, L. L., Jan 1 2016, In : Advances in Hematology. 2016, 7678901.Research output: Contribution to journal › Article
Factor VIIIa
Factor IX
Threonine
Post Translational Protein Processing
Factor XIa